-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
"It has long been known that tau deposition in the so-called hippocampus and adjacent brain regions impairs memory
Data collection at multiple sites
The data currently evaluated come from a long-term study (DELCODE) conducted by DZNE in cooperation with university hospitals, in which 10 research centers in Germany participated
Levels of amyloid and tau proteins in the cerebrospinal fluid are commonly used indicators to assess the burden of these proteins on the brain
Support anti-amyloid therapy
"Our data show several relevant associations
This is the anti-amyloid therapy using "monoclonal antibodies", which is currently undergoing clinical trials, of which "Aducanumab" (brand name: Aduhelm) is the first drug approved in the United States
Journal Reference :
Emrah Düzel, Gabriel Ziegler, David Berron, Anne Maass, Hartmut Schütze, Arturo Cardenas-Blanco, Wenzel Glanz, Coraline Metzger, Laura Dobisch, Martin Reuter, Annika Spottke, Frederic Brosseron, Klaus Fliessbach, Michael T Heneka, Christoph Laske, Oliver Peters, Josef Priller, Eike Jakob Spruth, Alfredo Ramirez, Oliver Speck, Anja Schneider, Stefan Teipel, Ingo Kilimann, Wiltfang Jens, Björn-Hendrik Schott, Lukas Preis, Daria Gref, Franziska Maier, Matthias H Munk, Nina Roy, Tomasso Ballarini, Renat Yakupov, John Dylan Haynes, Peter Dechent, Klaus Scheffler, Michael Wagner, Frank Jessen.
